The Most Polarizing Topics in Healthcare IT
23andMe. The FDA's crackdown last week on this human genome test kit that arrives at your house in an Amazon-style box has split my friends seemingly down the middle, irrespective of their level of technical knowledge. Libertarians in general argue that the FDA should get its cotton-pickin' hands out of 23andMe's business; consumer privacy advocates rail against seen and unseen third parties getting their cotton-pickin' hands on our most personal of data; and healthcare cost-control advocates wring their cotton-pickin' hands over the medically unadvised surgeries and tests prompted by social media–driven scientific theories that don't always square with science.
Epic. Those who adopt this market-dominating EHR are legion, and some of them are willing to enumerate in excruciating detail the benefits of it, as will become clear when you read my cover story in the January-February issue of HealthLeaders magazine. Of course, those providers not in the Epic camp worry about being frozen out of the Epic ecosystem. Meanwhile, more and more doctors in small practices are waking up to find that every major hospital in town is running Epic, forcing them to make a tough decision—stay free of Epic—or an expensive one—join the crowd.
- Ebola: Health Officials Try to Quell Front Line Fears
- Reducing Readmissions Starts with Better Collaboration
- Readmissions: No Quick Fix to Costly Hospital Challenge
- Ebola: A New Normal in Dallas
- Defensive Medicine Still Prevalent Despite Tort Reform
- Partners HealthCare M&A Deal Under Scrutiny
- 'Overtreatment' Debate Circles Back to Lung Cancer Screening
- Health Literacy Month Gets a Boost from Payers
- How Telehealth Pays Off for Providers, Patients
- How Educated Nurses Save Money